Compare · EUDA vs LFST
EUDA vs LFST
Side-by-side comparison of EUDA Health Holdings Limited (EUDA) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUDA and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.69B, about 108.8x EUDA ($43.1M).
- Over the past year, EUDA is down 63.4% and LFST is up 128.3% - LFST leads by 191.7 points.
- LFST has been more active in the news (17 items in the past 4 weeks vs 2 for EUDA).
- LFST has more recent analyst coverage (17 ratings vs 0 for EUDA).
- Company
- EUDA Health Holdings Limited
- LifeStance Health Group Inc.
- Price
- $16.60+10.52%
- $12.28+0.99%
- Market cap
- $43.1M
- $4.69B
- 1M return
- +10.52%
- +12.76%
- 1Y return
- -63.44%
- +128.25%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 2
- 17
- Recent ratings
- 0
- 17
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest EUDA
- SEC Form 424B3 filed by EUDA Health Holdings Limited
- SEC Form EFFECT filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
Latest LFST
- Director Deluca Teresa sold $95,100 worth of shares (7,500 units at $12.68), decreasing direct ownership by 7% to 97,093 units (SEC Form 4) (withholding tax)
- Director Deluca Teresa sold $249,993 worth of shares (20,441 units at $12.23), decreasing direct ownership by 16% to 104,593 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
- Director Burdick Kenneth A sold $5,755,000 worth of shares (500,000 units at $11.51), decreasing direct ownership by 14% to 2,970,810 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
- Chief Technology Officer Paunovich Vukasin sold $481,675 worth of shares (44,394 units at $10.85), decreasing direct ownership by 15% to 247,446 units (SEC Form 4)
- Large owner Tpg Gp A, Llc sold $144,890,858 worth of shares (13,643,207 units at $10.62) (SEC Form 4)
- Chief Operating Officer Miller Lisa K sold $519,845 worth of shares (47,912 units at $10.85), decreasing direct ownership by 15% to 281,289 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.